ARCHIVES

First-Line Tarceva Nearly Doubles PFS in EGFR-Activated Tumors

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: Robert Bast Succeeds Singleton As Director Of Duke Cancer Center; Robert Bell Deputy

August 14, 1987

NCI High School Summer Program Called Successful

October 19, 1990

Healy Sworn In, Calls For ‘Operation Bethesda Storm’

July 12, 1991

NCI Director Broder’s Year In Review: Avoid Politics, Stay Focused On Science

October 28, 1994

Health Care Delivery: Value Of Informatics To PPMs Is a Message for Academic Centers

November 22, 1996

Letter In Response To Hadley; RFA Available

July 7, 1995